Insulin Therapy Management
Introduction to Basal-Bolus Insulin Approach
- The American Diabetes Association recommends a basal-bolus insulin approach for effective glycemic management, which includes basal insulin (40 units Lantus at bedtime) and bolus insulin (15 units Novolog three times daily after meals) 1, 2
Hypoglycemia Risk Management
- The total daily insulin dose (40 units basal + 45 units bolus = 85 units) may be appropriate depending on the patient's weight, insulin sensitivity, and glycemic control, with a recommendation to monitor for signs of overbasalization if the basal dose exceeds ~0.5 units/kg/day 2
- For nocturnal hypoglycemia, reduce the Lantus dose by 10-20% (to approximately 32-36 units), with a strength of evidence supporting this adjustment 1, 3
- If hypoglycemia occurs without a clear reason, reduce the corresponding insulin dose by 10-20% 1, 2
Timing Considerations for Insulin Administration
- Post-meal Novolog administration can be appropriate, especially for patients with unpredictable eating patterns, as recommended by the American Diabetes Association 4
- Administer Lantus at the same time daily to maintain stable basal coverage, with evidence supporting the importance of consistent timing 5
Dose Adjustment Guidelines
- If hyperglycemia persists, assess the pattern and titrate gradually: increase Lantus by 2 units every 3 days until target fasting glucose is reached, with a moderate strength of evidence supporting this approach 1
- Increase Novolog by 1-2 units or 10-15% twice weekly, based on the patient's response and glycemic control, with evidence from the American Diabetes Association supporting this adjustment 2
Monitoring and Maintenance
- Perform frequent blood glucose testing, especially when adjusting doses, to ensure adequate monitoring and minimize the risk of hypoglycemia or hyperglycemia 4
- Adjust Novolog doses based on carbohydrate content of meals to optimize glycemic control, with evidence supporting the importance of meal planning 5
- Watch for clinical signals of overbasalization, such as elevated bedtime-to-morning glucose differential, hypoglycemia, or high glucose variability, and adjust the insulin dose accordingly 2